SageView Advisory Group’s Organogenesis Holdings ORGO Stock Holding History

SageView Advisory Group’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$974	Buy	+188	New	+$911	﹤0.01%	2363

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SageView Advisory Group's ORGO Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Organogenesis Holdings (ORGO) in Q4 2025: 188 shares worth $974. The stake represents ﹤0.01% of the portfolio and ranks #2363 among its holdings.

147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

SageView Advisory Group held 188 shares of Organogenesis Holdings worth $974 as of Q4 2025.
Organogenesis Holdings was a new SageView Advisory Group position in Q4 2025.
Organogenesis Holdings made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2363 holding.
147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.